Lung Preservation w/ Tocilizumab in Early Systemic Sclerosis
Arthritis & Rheumatology has published the results of a subanalysis from TCZ clinical trials showing that Il-6 inhibition is related with preservation of lung function patients with early SSc.
https://t.co/2BwWQWEkri https://t.co/pjVc8YTDwU
Links:
Feb-23-2021


